DE69834262D1 - Neue pharnazeutische verwendung von c-c chemokin produktionsinhibitoren - Google Patents
Neue pharnazeutische verwendung von c-c chemokin produktionsinhibitorenInfo
- Publication number
- DE69834262D1 DE69834262D1 DE69834262T DE69834262T DE69834262D1 DE 69834262 D1 DE69834262 D1 DE 69834262D1 DE 69834262 T DE69834262 T DE 69834262T DE 69834262 T DE69834262 T DE 69834262T DE 69834262 D1 DE69834262 D1 DE 69834262D1
- Authority
- DE
- Germany
- Prior art keywords
- chemokin
- pharmaceutical use
- new pharmaceutical
- production inhibitors
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
- A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Tropical Medicine & Parasitology (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25096697 | 1997-09-16 | ||
JP25096697 | 1997-09-16 | ||
PCT/JP1998/004164 WO1999013880A1 (fr) | 1997-09-16 | 1998-09-16 | Inhibiteur de la production de chemokine c-c |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69834262D1 true DE69834262D1 (de) | 2006-05-24 |
DE69834262T2 DE69834262T2 (de) | 2006-09-07 |
Family
ID=17215679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69834262T Expired - Lifetime DE69834262T2 (de) | 1997-09-16 | 1998-09-16 | C-C Chemokine Produktionsinhibitoren |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1016408B1 (de) |
JP (1) | JP4314742B2 (de) |
CA (1) | CA2303343C (de) |
DE (1) | DE69834262T2 (de) |
WO (1) | WO1999013880A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2304955T3 (es) * | 1999-05-10 | 2008-11-01 | Toray Industries, Inc. | Medicamentos contra la insuficiencia renal. |
US20030092760A1 (en) | 2001-03-12 | 2003-05-15 | Toray Industries, Inc. | Therapeutic agent for renal failure |
JP2004517078A (ja) * | 2000-12-01 | 2004-06-10 | シェーリング コーポレイション | 哺乳動物遺伝子および関連試薬の使用 |
DE10225551A1 (de) * | 2002-06-06 | 2003-12-24 | Schering Ag | Verwendung von oral verfügbaren Prostacyclinderivaten für die Herstellung eines Arzneimittels zur Behandlung von Krankheiten, die mit Knochenmarködemen assoziiert sind |
EP1627638B1 (de) * | 2003-05-09 | 2017-07-12 | Toray Industries, Inc. | Beraprost und ein inhibitor des renin-angiotensin-systems zur verwendung bei der behandlung von nierenerkrankungen |
WO2007007668A1 (ja) * | 2005-07-08 | 2007-01-18 | Toray Industries, Inc. | ***改善のための治療剤および処置方法 |
CA2744391A1 (en) * | 2008-12-05 | 2010-06-10 | Intermed Discovery Gmbh | Inhibitors of hif-1 protein accumulation |
CN102655866B (zh) | 2009-11-13 | 2013-11-13 | 东丽株式会社 | 糖尿病的治疗或预防药 |
TW201713575A (zh) | 2015-09-30 | 2017-04-16 | 陶氏全球科技有限責任公司 | 具有乙烯/α-烯烴多嵌段共聚物的配件 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5931510B2 (ja) * | 1979-09-03 | 1984-08-02 | 東レ株式会社 | 5,6,7−トリノル−4,8−インタ−m−フエニレンPGI↓2誘導体 |
JPS57144276A (en) * | 1981-03-03 | 1982-09-06 | Toray Ind Inc | 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivative |
EP0365678B1 (de) * | 1987-10-16 | 1994-01-05 | Toray Industries, Inc. | 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLEN 2-PGI-DERIVATE, VERFAHREN ZUR HERSTELLUNG UND DEREN VERWENDUNG |
JPH07188205A (ja) * | 1993-12-27 | 1995-07-25 | Ishihara Sangyo Kaisha Ltd | α−グルコシダーゼ阻害剤 |
-
1998
- 1998-09-16 WO PCT/JP1998/004164 patent/WO1999013880A1/ja active IP Right Grant
- 1998-09-16 CA CA2303343A patent/CA2303343C/en not_active Expired - Lifetime
- 1998-09-16 JP JP2000511502A patent/JP4314742B2/ja not_active Expired - Lifetime
- 1998-09-16 EP EP98943009A patent/EP1016408B1/de not_active Expired - Lifetime
- 1998-09-16 DE DE69834262T patent/DE69834262T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69834262T2 (de) | 2006-09-07 |
JP4314742B2 (ja) | 2009-08-19 |
CA2303343A1 (en) | 1999-03-25 |
EP1016408A1 (de) | 2000-07-05 |
EP1016408A4 (de) | 2003-03-05 |
CA2303343C (en) | 2011-01-04 |
WO1999013880A1 (fr) | 1999-03-25 |
EP1016408B1 (de) | 2006-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE239011T1 (de) | Neuartige form von s-omeprazol | |
DE19681286T1 (de) | Neue Kristallform von Olanzapin | |
DE69821072D1 (de) | Echtzeit bildgesteuerte Positionierung von Verankerungseinheiten | |
DE69813616D1 (de) | Cyclohexencarboxylate als inhibitoren der neuraminidase | |
DE69927128D1 (de) | Verwendung von topisch applizierbaren Gerinnungsmaterial | |
DE69822186D1 (de) | Herstellung von mustern | |
DE59905858D1 (de) | Verwendung von pit-emulsionen | |
DE60041145D1 (de) | Nutzung von daten | |
DE69633333D1 (de) | Diphosphonatderivate von therapeutischen substanzen | |
ATE263147T1 (de) | Derivate von aryloxyarylsulfonylamino hydroxyaminsäuren | |
DE60033896D1 (de) | Unterscheidung von Modulationsarten | |
DE50012379D1 (de) | Verwendung von nanoskaligen antischuppenwirkstoffen | |
DK1027332T3 (da) | Hidtil ukendte lactametalloproteaseinhibitorer | |
ATE293477T1 (de) | Neue verwendung von lipase-inhibitoren | |
ATE315383T1 (de) | Beschichtung von tablettenkernen | |
FI971784A (fi) | Apolipoproteiini B-synteesin estäjiä | |
DE69613818D1 (de) | Inhibierung von hydratbildung | |
NO983632L (no) | Krystallform av N-(4-trifluormetylfenyl)-5-metyl-isoksazol-4-karboksamid | |
ID22650A (id) | Penggunaan penghambat-penghambat lipase usus lambung | |
EE9700093A (et) | Apolipoproteiin-B sünteesi inhiibitorid | |
DE69628195D1 (de) | Verwendung von xyloglucanendotransglycosylase | |
ID26137A (id) | Komposisi farmasi baru dari uridin trifosfat | |
DE69801878D1 (de) | Verwendung von Oxamatderivaten als Depigmentierungsmittel | |
DE69629962D1 (de) | Inhibierung von Exoprotein in absorbierenden Produkten | |
DE69531048D1 (de) | Verwendung von steroidsulphatase-hemmern |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |